Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 9,220 shares of Auna stock in a transaction that occurred on Thursday, May 28th. The shares were bought at an average price of $4.17 per share, for a total transaction of $38,447.40. Following the transaction, the president owned 55,134 shares of the company’s stock, valued at $229,908.78. This represents a 20.08% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora acquired 6,420 shares of Auna stock. The shares were bought at an average price of $4.15 per share, for a total transaction of $26,643.00.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 30,000 shares of Auna stock. The shares were bought at an average price of $4.39 per share, for a total transaction of $131,700.00.
- On Wednesday, May 20th, Leon Jesus Zamora acquired 5,814 shares of Auna stock. The shares were bought at an average price of $4.39 per share, for a total transaction of $25,523.46.
- On Wednesday, May 27th, Leon Jesus Zamora acquired 23,273 shares of Auna stock. The shares were bought at an average price of $4.20 per share, for a total transaction of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 8,727 shares of Auna stock. The shares were bought at an average price of $4.24 per share, for a total transaction of $37,002.48.
Auna Stock Performance
Shares of Auna stock opened at $4.54 on Tuesday. Auna S.A. has a one year low of $4.09 and a one year high of $6.85. The company has a market cap of $336.01 million, a price-to-earnings ratio of 17.46 and a beta of 0.82. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. The business’s 50 day moving average price is $5.20 and its 200 day moving average price is $5.01.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC grew its stake in Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock worth $3,683,000 after purchasing an additional 554,707 shares in the last quarter. Marshall Wace LLP grew its stake in Auna by 391.0% during the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after purchasing an additional 129,799 shares in the last quarter. Lazard Asset Management LLC acquired a new position in Auna during the 1st quarter worth $557,000. Goldman Sachs Group Inc. grew its stake in Auna by 43.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock worth $352,000 after purchasing an additional 21,579 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in Auna during the 1st quarter worth $324,000.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on AUNA shares. JPMorgan Chase & Co. reduced their target price on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. Wall Street Zen downgraded Auna from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 16th. Finally, Zacks Research downgraded Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $6.97.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Recommended Stories
- Five stocks we like better than Auna
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
